|
Mylan Inc., which provides products to customers in more than 140 countries and territories, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest - and highest quality - product portfolios, supported by a robust pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory and allergy therapies.
Recent Releases
Nov 18, 2009
Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
Nov 12, 2009
Mylan's Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier
View all releases »
|
| Stock Chart |
|
| Stock Quote |
| Mylan (NASDAQ: MYL) |
| Price: |
17.55 |
| Change: |
+ 0.12 |
| Day High: |
17.63 |
| Day Low: |
17.31 |
| Volume: |
4,080,200 |
Delayed at least 20 minutes.
Provided by eSignal. |
|